The LAMEA prazosin market is estimated to grow significantly during the forecast period. The factors contributing to the growth of the indapamide market include rising cases of diabetes and hypertension among the population. According to the International Diabetes Federation (IDF), Brazil and Mexico are the two countries with a higher number of diabetes cases registered in the region. In Mexico, an estimated 12 million cases were registered in 2017. Additionally, the diabetes cases are expected to rise by 35% to an estimated 16 million cases by 2045 in Mexico. Moreover, according to the World Health Organization (WHO), diabetes is the second-most common cause of mortality in Mexico. Hence, indapamide drugs have great potential to offer for diabetes in the market of the RoW region. Some of the major factors that are contributing to the increasing cases of diabetes include rapid urbanization and changing lifestyles across the region.

A full report of Latin America and Middle & Africa (LAMEA) Indapamide Market is available at: https://www.omrglobal.com/industry-reports/lamea-indapamide-market

The LAMEA indapamide market is segmented on the basis of product and application. Based on the product, the market is bifurcated into 1.25 mg indapamide and 2.5 mg indapamide. Among these, the market for 1.25 mg medicine held a significant share owing to the extensive application of the drug in treating high blood pressure or hypertension. Based on the application, the market is segmented into high blood pressure, heart failure, and others. The high blood pressure segment is projected to have a significant share in the market. Growing incidence of hypertension is contributing to market growth as indapamide drugs are significantly used to treat hypertension while reducing the risk of developing serious heart conditions.

To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/lamea-indapamide-market

Some of the global companies operating in the LAMEA indapamide market include ANI Pharmaceuticals, Inc., Apotex Inc., Sanofi S.A., Teva Pharmaceuticals Industries Ltd., Mylan N.V., and others. The market players are considerably contributing to market growth by adopting various strategies to stay competitive in the market.

Latin America and Middle & Africa (LAMEA) Indapamide Market- Segmentation

By Product

• 1.25 MG
• 2.5 MG

By Application

• High Blood Pressure
• Heart Failure
• Others

For more customized data, request for report customization @ https://www.omrglobal.com/report-customization/lamea-indapamide-market

Latin America and Middle & Africa (LAMEA) Indapamide Market– Segment by Region

• Latin America
• Middle East
• Africa

Company Profiles

• ANI Pharmaceuticals, Inc.
• Glenmark Pharmaceuticals Ltd.
• Grupo Azevedos
• Krka Group
• Mylan N.V.
• Merck KGaA
• Sanofi S.A.
• Sandoz International GmbH
• Servier Group
• Teva Pharmaceuticals Industries Ltd.


About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

For More Information, Visit https://www.omrglobal.com

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: [email protected]
Contact no: +1 646-755-7667, +91 7803040404